Stephen H Mandy (L Meneghini, Luigi F Meneghini, Luigi Meneghini)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 21

Top Venues

Diabetes, obesity & metabolism

Diabetes care

Clinical diabetes : a publication of the American Diabetes Association

Diabetic medicine : a journal of the British Diabetic Association

The University of Texas Southwestern Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Texas Southwestern Medical Center Jan 02 2014

United States

Professor :: Internal Medicine

Publications

Felona Gunawan, Syed Ajaz, Stephen H Mandy, Uma Gunasekaran
Benefits of Electronic Consultations in Improving Diabetes Care Within a Safety-Net Health System. Clinical diabetes : a publication of the American Diabetes Association 41 (2) (2023)
Felona Gunawan, Syed Ajaz, Stephen H Mandy, Uma Gunasekaran
Benefits of Electronic Consultations in Improving Diabetes Care Within a Safety-Net Health System. Clinical diabetes : a publication of the American Diabetes Association 41 (2) (2023)
Felona Gunawan, Syed Ajaz, Stephen H Mandy, Uma Gunasekaran
Benefits of Electronic Consultations in Improving Diabetes Care Within a Safety-Net Health System. Clinical diabetes : a publication of the American Diabetes Association 41 (2) (2023)
Felona Gunawan, Syed Ajaz, Stephen H Mandy, Uma Gunasekaran
Benefits of Electronic Consultations in Improving Diabetes Care Within a Safety-Net Health System. Clinical diabetes : a publication of the American Diabetes Association 41 (2) (2023)
Kiran K Chatha, Brad Walsh, Javier La Fontaine, Michael E Bowen, Stephen H Mandy
Lower-Extremity Amputation Trends Among People With Diabetes in a Large Urban Environment. Diabetes care 44 (5) (2021)
Rodolfo Alejandro, Alessia Fornoni, Stephen H Mandy, Alberto Pugliese, Ronald B Goldberg
Daniel H. Mintz (1930-2020): An Extraordinary Physician-Scientist and a Pioneer in Islet Transplantation. Diabetes care 44 (8) (2021)
Carolyn Smith-Morris, Sylvia Rodriguez, Rose Soto, Morningstar Spencer, Stephen H Mandy
Decolonizing Care at Diagnosis: Culture, History, and Family at an Urban Inter-tribal Clinic. Medical anthropology quarterly 35 (3) (2021)
Udoka Obinwa, Adriana Pérez, Ildiko Lingvay, Stephen H Mandy, Ethan A Halm, Michael E Bowen
Multilevel Variation in Diabetes Screening Within an Integrated Health System. Diabetes care 43 (5) (2020)
Michael H Gold, Anneke Andriessen, Shasa Hu, Janelle M K Vega, David J Goldberg, Komel V Grover, Z Paul Lorenc, Stephen H Mandy
Physician survey on pre-/postprocedure measures for injectable treatments. Journal of cosmetic dermatology 19 (9) (2020)
Stephen R Benoit, Vivian A Fonseca, Roy E Furman, Stephen H Mandy, Lizheng Shi
Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications: A Simulation Study. Diabetes care 43 (11) (2020)
Stephen H Mandy, Lawrence Blonde, Jasvinder Gill, Arnaud Dauchy, Andrius Bacevicius, Jodi Strong, Timothy S Bailey
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trial. Diabetes, obesity & metabolism 22 (11) (2020)
Stephen H Mandy, Sean D Sullivan, Gerry Oster, Robert Busch, Anna M G Cali, Arnaud Dauchy, Jasvinder Gill, Timothy S Bailey
A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study. Diabetes, obesity & metabolism 22 (11) (2020)
Marconi Abreu, Anna Tumyan, Ahmed Elhassan, Katherine Peicher, Olivia Papacostea, Perihan Dimachkie, Muhammad S Siddiqui, Laurentiu M Pop, Uma Gunasekaran, Stephen H Mandy, Beverley Adams-Huet, Xilong Li, Ildiko Lingvay
A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal insulin: The SIMPLE study. Diabetes, obesity & metabolism 21 (9) (2019)
Stephen H Mandy, A Doshi, D Gouet, T Vilsbøll, K Begtrup, P Őrsy, M F Ranthe, I Lingvay
Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin. Diabetic medicine : a journal of the British Diabetic Association 37 (2) (2019)
Fang Liz Zhou, Charlie J Nicholls, Lin Xie, Yuexi Wang, Neel Vaidya, Stephen H Mandy
Hypoglycaemia and treatment patterns among insulin-treated patients with type 2 diabetes who switched to insulin glargine 300 units/mL versus other basal insulin in a real-world setting. Endocrinology, diabetes & metabolism 2 (3) (2019)
Jeremy Pettus, Ronan Roussel, Fang Liz Zhou, Zsolt Bosnyak, Jukka Westerbacka, Rachele Berria, Javier Jimenez, Björn Eliasson, Irene Hramiak, Timothy Bailey, Stephen H Mandy
Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 10 (2) (2019)
David R Owens, Wolfgang Landgraf, Brian M Frier, Mei Zhang, Philip D Home, Stephen H Mandy, Geremia B Bolli
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0. Diabetes, obesity & metabolism 21 (2) (2019)
Stephen H Mandy, Esmeralda Castelblanco, Emanuela Orsi, Nebojsa M Lalic, Anna M G Cali, Jukka Westerbacka, Peter Stella, Christophe Candelas Dea, Valerie Pilorget, Riccardo Perfetti, Kamlesh Khunti, null null
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting. Diabetes, obesity & metabolism 21 (6) (2019)
Stephen H Mandy, Lulu K Lee, Shaloo Gupta, Ron Preblick
Association of hypoglycaemia severity with clinical, patient-reported and economic outcomes in US patients with type 2 diabetes using basal insulin. Diabetes, obesity & metabolism 20 (5) (2018)
Juan Pablo Frias, Manuel Puig Domingo, Stephen H Mandy, Raffaele Napoli, Minzhi Liu, Erika Soltes Rak, Vanita R Aroda
More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L. Diabetes, obesity & metabolism 20 (9) (2018)
Fang Liz Zhou, Lin Xie, Chunshen Pan, Yuexi Wang, Neel Vaidya, Fen Ye, Ronald Preblick, Stephen H Mandy
Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin. Diabetes, obesity & metabolism 20 (5) (2018)

Stephen H Mandy.css-eqlu8i{font-size:small;padding-left:4px;} (L Meneghini, Luigi F Meneghini, Luigi Meneghini)

Publication Activity (10 Years)

Top Topics

Top Venues

Stephen H Mandy (L Meneghini, Luigi F Meneghini, Luigi Meneghini)